Bolder BioPATH Revenue and Competitors
Estimated Revenue & Valuation
- Bolder BioPATH's estimated annual revenue is currently $3.4M per year.
- Bolder BioPATH's estimated revenue per employee is $201,000
Employee Data
- Bolder BioPATH has 17 Employees.
- Bolder BioPATH grew their employee count by -23% last year.
Bolder BioPATH's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | VP Research | Reveal Email/Phone |
3 | Associate Director Pharmacology | Reveal Email/Phone |
4 | Pathologist | Reveal Email/Phone |
5 | Animal Care and Facility Coordinator | Reveal Email/Phone |
Bolder BioPATH Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6M | 30 | 0% | N/A | N/A |
#2 | $9.6M | 48 | -6% | N/A | N/A |
#3 | $3.4M | 17 | -23% | N/A | N/A |
#4 | $195M | 128 | 0% | $121.4M | N/A |
#5 | $5.8M | 29 | -19% | N/A | N/A |
#6 | $5.8M | 29 | -15% | N/A | N/A |
#7 | $5.8M | 29 | 21% | N/A | N/A |
#8 | $4.2M | 42 | -11% | $138M | N/A |
#9 | $4.4M | 22 | -8% | N/A | N/A |
#10 | $19.9M | 99 | 22% | N/A | N/A |
What Is Bolder BioPATH?
Bolder BioPATH, Inc. is a contract pharmacology, toxicology and pathology company specializing in In Vivo models of rheumatoid arthritis, osteoarthritis and cancer as well as other autoimmune and inflammation models, Our goals are to provide preclinical (efficacy and toxicity) data to support advancing proteins and small molecules to IND/NDA stage.
keywords:N/A
N/A
Total Funding
17
Number of Employees
$3.4M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boulder
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.6M | 17 | 42% | N/A |
#2 | $1.5M | 17 | -15% | N/A |
#3 | $1.5M | 17 | -23% | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $2.8M | 17 | 6% | N/A |